Cite

HARVARD Citation

    Savira, F. et al. (2021). Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective. European journal of preventive cardiology. pp. 975-982. [Online]. 
  
Back to record